Table 1. Clinical data of pediatric patients with nephrotic syndrome (NS) during acute and remission phases.
Data are presented as median (interquartile range) and compared using the Wilcoxon signed-rank test. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides. P < 0.05 was considered statistically significant.
| Parameters | NS–acute phase (n=33) | NS–remission phase (n=33) | P-value |
|---|---|---|---|
| Age (years) | 5(3–7.5) | 5(3–8) | 0.068 |
| Gender, M/F | 22/11 | 22/11 | 1.000 |
| BMI, kg/m2 | 18 (17.3–18.8) | 16.5 (15.3–17.7) | 0.001 |
| SBP, mmHg | 110 (99–120) | 103 (100–119) | 0.635 |
| DBP, mmHg | 70 (60–80) | 68 (60–79) | 0.422 |
| Glucose, mmol/L | 5.1 (4.3–6.1) | 4.8 (4.3–5.3) | 0.069 |
| Urea, mmol/L | 4.3 (3.3–5.9) | 4.5 (4.1–5.7) | 0.820 |
| Creatinine, μmol/L | 34 (26–41) | 39 (31–49) | 0.086 |
| Total protein, g/L | 42 (38–48) | 62 (57–68) | 0.001 |
| Albumin, g/L | 11 (8–18) | 31 (26–36) | < 0.001 |
| TC, mmol/L | 9.5 (7.1–11.6) | 7.1 (6.0–8.3) | < 0.001 |
| LDL-C, mmol/L | 7.1 (4.6–8.9) | 3.6 (2.8–5.5) | < 0.001 |
| HDL-C, mmol/L | 1.3 (0.9–1.7) | 2.2 (1.8–2.8) | < 0.001 |
| TG, mmol/L | 2.0 (1.3–2.9) | 1.7 (1.0–2.0) | 0.013 |